WATCHMAN device-related thrombus successfully treated with apixaban: A case report.

ABSTRACT:

Rationale

Among atrial fibrillation patients with high risk of bleeding, left atrial appendage occlusion has emerged as an alternative to long-term oral anticoagulation therapy for stroke prevention. Device-related thrombus remains a major concern because it may result in recurrent embolic events. To date, there is no consensus on the optimal method of treating device-related-thrombus.

Patient concerns

A 78-year-old man with atrial fibrillation had an episode of intracranial hemorrhage while taking warfarin. He subsequently underwent percutaneous placement of a 30-mm Watchman device to the left atrial appendage. He was prescribed dual anti-platelet therapy with aspirin and clopidogrel.

Diagnosis

Reassessment echocardiography 3 months later found device-related thrombu

SUBMITTER: Wong CK 

PROVIDER: S-EPMC5708950 | biostudies-literature | 2017 Nov

REPOSITORIES: biostudies-literature